Evidence mapPaperPMID 36930654Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2023

Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes.

Hannah K Fandl, Vinicius P Garcia, John W Treuth, Lillian M Brewster, Jared J Greiner, Kevin P Davy, Brian L Stauffer, Christopher A Desouza

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Endothelial Dysfunction in Obesity and Therapeutic Targets.Advances in experimental medicine and biology · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Endothelial cell dysfunction in cardiac disease: driver or consequence?Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hannah K FandlIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States.ORCID 0000-0002-4971-0738
Vinicius P GarciaIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States.
John W TreuthIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States.
Lillian M BrewsterIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States.ORCID 0000-0002-5571-4268
Jared J GreinerIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States.
Kevin P DavyHuman Integrative Physiology Laboratory, Department of Human Nutrition, Foods, and Exercise, Virginia Tech University, Blacksburg, Virginia, United States.
Brian L StaufferDivision of Cardiology, Denver Health Medical Center, Denver, Colorado, United States.
Christopher A DesouzaIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado, United States.ORCID 0000-0001-9372-5083
University of Colorado Boulder · USDenver Health Medical Center · USVirginia Tech · US

Funding

Aging, Exercise and Endothelin-1 Vasoconstrictor ToneR01HL077450 · UNIVERSITY OF COLORADO AT BOULDER · 2004 to 2005
$711k
NCATS NIH HHS UL1 TR002535NHLBI NIH HHS R01 HL077450NHLBI NIH HHS R01 HL107715
6 · The paper itself

Abstract

Obesity and hypertension, independently and combined, are associated with increased risk of heart failure and heart failure-related morbidity and mortality. Interest in circulating endothelial cell-derived microvesicles (EMVs) has intensified because of their involvement in the development and progression of endothelial dysfunction, atherosclerosis, and cardiomyopathy. The experimental aim of this study was to determine, in vitro, the effects of EMVs isolated from obese/hypertensive adults on key proteins regulating cardiomyocyte hypertrophy [cardiac troponin T (cTnT), α-actinin, nuclear factor-kB (NF-kB)] and fibrosis [transforming growth factor (TGF)-β, collagen1-α1], as well as endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) production. EMVs (CD144

Indexed as

Cell-Derived MicroparticlesHeart FailureHypertensionActininAdultFemaleFibrosisHumansHypertrophyMaleMiddle AgedMyocytes, CardiacNF-kappa BNitric OxideNitric Oxide Synthase Type IIIObesityActininNF-kappa BNitric OxideNitric Oxide Synthase Type IIITransforming Growth Factor betaTroponin Tcardiomyocytesendothelial microvesiclesfibrosishypertrophynitric oxide

Identifiers

PMID36930654
PMCPMC10085555
OpenAlexW4327683219

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.